Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease
- 9 August 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 118 (5), 605-616
- https://doi.org/10.1007/s00401-009-0581-5
Abstract
Neuronal intermediate filament inclusion disease (NIFID) is an uncommon neurodegenerative condition that typically presents as early-onset, sporadic frontotemporal dementia (FTD), associated with a pyramidal and/or extrapyramidal movement disorder. The neuropathology is characterized by frontotemporal lobar degeneration with neuronal inclusions that are immunoreactive for all class IV intermediate filaments (IF), light, medium and heavy neurofilament subunits and α-internexin. However, not all the inclusions in NIFID are IF-positive and the primary molecular defect remains uncertain. Mutations in the gene encoding the fused in sarcoma (FUS) protein have recently been identified as a cause of familial amyotrophic lateral sclerosis (ALS). Because of the recognized clinical, genetic and pathological overlap between FTD and ALS, we investigated the possible role of FUS in NIFID. We found abnormal intracellular accumulation of FUS to be a consistent feature of our NIFID cases (n = 5). More neuronal inclusions were labeled using FUS immunohistochemistry than for IF. Several types of inclusions were consistently FUS-positive but IF-negative, including neuronal intranuclear inclusions and glial cytoplasmic inclusions. Double-label immunofluorescence confirmed that many cells had only FUS-positive inclusions and that all cells with IF-positive inclusions also contained pathological FUS. No mutation in the FUS gene was identified in a single case with DNA available. These findings suggest that FUS may play an important role in the pathogenesis of NIFID.Keywords
This publication has 41 references indexed in Scilit:
- A new subtype of frontotemporal lobar degeneration with FUS pathologyBrain, 2009
- Rethinking ALS: The FUS about TDP-43Cell, 2009
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsActa Neuropathologica, 2008
- The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress responseBMC Cell Biology, 2008
- Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusionsBrain, 2008
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar DegenerationActa Neuropathologica, 2007
- Neurodegeneration with Features of NIFID and ALS—Extended Clinical and Neuropathological SpectrumBrain Pathology, 2006
- Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID)Neurobiology of Aging, 2006
- Neurofilaments and neurological diseaseBioEssays, 2003
- Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferationOncogene, 1999